<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11483">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01754506</url>
  </required_header>
  <id_info>
    <org_study_id>2011H0228</org_study_id>
    <secondary_id>1R21NR012803-01A1</secondary_id>
    <nct_id>NCT01754506</nct_id>
  </id_info>
  <brief_title>Testing Fish Oil Derivatives In Healing Of Chronic Venous Leg Ulcers</brief_title>
  <official_title>Testing Fish Oil Derivatives In Healing Of Chronic Venous Leg Ulcers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ohio State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Nursing Research (NINR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test the efficacy of an oral, nutrient intervention
      containing the bioactive components of fish oil to promote healing of chronic venous leg
      ulcers (CVLU). If this systemic, nutrient intervention is found to alter the
      microenvironment of CVLU, the science of wound healing and care of patients with CVLU will
      be vastly improved.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The pathogenesis of CVLU involves high numbers of activated polymorphonuclear leukocytes
      (PMN) that are associated with persistent inflammation in the wound bed 5-9. We propose to
      test the efficacy of an oral, nutrient intervention containing the bioactive components of
      fish oil to assuage PMN activity and promote healing of CVLU. If this systemic, nutrient
      intervention is found to alter the microenvironment of CVLU, the science of wound healing
      and care of patients with CVLU will be vastly improved.

      The purpose of this study is to test three fundamental corollaries of our organizing
      hypothesis in a 2-group, double-blind, randomized, experimental design on CVLU patients. The
      findings from the proposed experiments will increase our understanding of lipid mediators
      that influence wound healing and PMN function, and may lead to an innovative approach to
      reduce the physical and emotional burdens of nonhealing or recurrent CVLU.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Levels of eicosapentaenoic (EPA)+ docosahexaenoic (DHA)-derived lipid mediators and proinflammatory cytokines in CVLU wound fluid</measure>
    <time_frame>56 days</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>PMN counts and levels of PMN-derived proteases in CVLU wound fluid</measure>
    <time_frame>56 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Increases in re-epithelialization</measure>
    <time_frame>56 days</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">108</enrollment>
  <condition>Venous Stasis Ulcers</condition>
  <arm_group>
    <arm_group_label>EPA+DHA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>EPA+DHA (fish oil)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fish Oil</intervention_name>
    <description>EPA + DHA Group subjects (n=54) will be given n-3 fatty acid supplement softgels</description>
    <arm_group_label>EPA+DHA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  men and women

          -  ages 18-85 years

          -  having at least one existing CVLU between the ankle and knee for ≥ 3 months

          -  medical clearance to take 81mg/d of aspirin

          -  prescribed compression therapy; ambulatory

          -  ankle brachial pressure index (ABPI) of ≥ 0.8

          -  target wound of ≥ 1 x 1 inches (6.25 cm2)

          -  can understand English and sign own consent

        Exclusion Criteria:

          -  allergy to fish or seafood

          -  exposed bone, tendon or fascia around target wound

          -  receiving warfarin or Plavix therapy

          -  immunologic related condition (e.g. Crohn's disease, systemic lupus erythematosus)

          -  chronic inflammatory skin diseases (e.g. pyoderma gangrenosum, psoriasis)

          -  requiring non-steroidal anti-inflammatory drugs &gt; 2x a week

          -  nutritional supplements or corticosteroids

          -  chronic renal insufficiency

          -  already in a study related to CVLU.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jodi C McDaniel, PhD, RN</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Ohio State University College of Nursing</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jodi C McDaniel, PhD, RN</last_name>
    <phone>614-292-1345</phone>
    <email>jmcdaniel@con.ohio-state.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Barbara A Brown, MA, RT</last_name>
    <phone>614-292-0151</phone>
    <email>bbrown@con.ohio-state.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Ohio State University College of Nursing</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barbara A Brown, MA, RT</last_name>
      <phone>614-292-0151</phone>
      <email>bbrown@con.ohio-state.edu</email>
    </contact>
    <investigator>
      <last_name>Jodi C McDaniel, PhD, RN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 26, 2013</lastchanged_date>
  <firstreceived_date>December 13, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Jodi McDaniel</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>leg ulcers</keyword>
  <keyword>wounds</keyword>
  <keyword>fish oil</keyword>
  <keyword>lipid mediators</keyword>
  <keyword>chronic venous stasis ulcers</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Leg Ulcer</mesh_term>
    <mesh_term>Postphlebitic Syndrome</mesh_term>
    <mesh_term>Postthrombotic Syndrome</mesh_term>
    <mesh_term>Varicose Ulcer</mesh_term>
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
